Advances in the treatment of solid tumors in children and adolescents
作者机构：Beijing Key Laboratory of Pediatric Hematology OncologyKey Laboratory of Major Diseases in ChildrenNational Key Discipline of Pediatrics(Capital Medical University)Ministry of EducationBeijing Children's HospitalHematology CenterNational Center for Children's HealthCapital Medical UniversityBeijingChina Department of Medical OncologyNational Cancer CenterNational Clinical Research Center for CancerCancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
出 版 物：《Cancer Innovation》 (肿瘤创新（英文）)
年 卷 期：2023年第2卷第2期
页 面：131-139页
学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题：children and adolescents immune checkpoint inhibitors treatment tumor
摘 要：Tumor is one of the leading causes of death in children(0 to 14-year-old)and adolescents(15 to 19-year-old)*** adult tumors,childhood and adolescent tumors are unique in their type,molecular characteristics,and pathogenesis,and their treatment involves many *** recent years,with the development of a large number of clinical studies,the survival rate of children and adolescents with tumors has improved *** extensive research and application of optimized treatment regimens and new targeted drugs have led to new hope for the treatment of childhood and adolescent *** article reviews the clinical and basic research and treatment of childhood and adolescent tumors and provides new ideas for the future development of precise treatment of childhood and adolescent tumors.
维普期刊数据库